- G71.0341 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM G71.0341 became effective on October 1, 2022.
- This is the American ICD-10-CM version of G71.0341 – other international versions of ICD-10 G71.0341 may differ.
ICD-10-CM G71.0341 is grouped within Diagnostic Related Group(s):
- 091 Other disorders of nervous system with mcc
- 092 Other disorders of nervous system with cc
- 093 Other disorders of nervous system without cc/mcc
Applicable To
- Alpha sarcoglycanopathy
- Limb-girdle muscular dystrophy due to alpha-sarcoglycan deficiency
- Limb girdle muscular dystrophy type 2D
Code History
- 2024 (effective 10/1/2022): New code
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to G71.0341:
- alpha-sarcoglycan-related > limb-girdle G71.039
- due to > limb-girdle G71.039
- alpha sarcoglycan dysfunction > due to G71.0341
- R3 (autosomal recessive) > limb-girdle G71.039
- type 2D (autosomal recessive) > limb-girdle G71.039
- alpha > Sarcoglycanopathy G71.0340